Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis

Cancer Science

Volumn 94, Issue 12, 2003, Pages 1083-1090

  Tarao, Kazuo ^a   Rino, Yasushi ^a   Takemiya, Shoji ^a   Ohkawa, Shinichi ^a   Sugimasa, Yukio ^a   Miyakawa, Kaoru ^a   Tamai, Setsuo ^a   Masaki, Takahiro ^a   Hirokawa, Satoru ^a   Kameda, Yoichi ^a   Nagaoka, Tadashi ^a   Okamoto, Naoyuki ^a   Kokubu, Shigehiro ^b   Yoshida, Muneki ^b   Kakita, Akira ^b  

^a KANAGAWA CANCER CENTER   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATIC VEIN; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

AGED; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 0346399559     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01404.x     Document Type: Article

References (28)

1. Child CG III, Turcotte JG. Surgery and portal hypertension. In: Dunphy JE, editor. The liver and portal hypertension. Philadelphia: WB Saunders; 1964. p. 50.
2. Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K, Aoki H, Imada T, Shindo K, Okamoto N, Totsuka S. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999; 86: 589-95.
3. Tarao K, Takemiya S, Tamai S, Sugimasa Y, Ohkawa S, Akaike M, Tanabe H, Shimizu A, Yoshida M, Kakita A. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 1997; 79: 688-94.
4. Tarao K, Rino Y, Takemiya S, Tamai S, Ohkawa S, Sugimasa Y, Miyakawa K, Morinaga S, Yoshida M, Shibuya A, Kokubu S, Kakita A, Endo O. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology 2000; 43: 20-6.
5. Tarao K, Hoshino H, Shimizu A, Ohkawa S, Nakamura Y, Harada M, Ito Y, Tamai S, Akaike M, Sugimasa Y, Takemiya S, Okamoto T, Okamoto N. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma. Jpn J Cancer Res. 1994; 85: 1040-4.
6. Tong MJ, Sun SC, Schaeffer BT, Chang NK, Lo KJ, Peters PL. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med. 1971; 75: 687-791.
7. Beasley RP, Hwant LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981; ii: 1129-33.
8. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-7.
9. Colombo M, Kuo G, Choo OL, Donato MF, Ninno FD, Tommasini MA, Dioguard N, Hovghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; ii: 1006-8.
10. Kobayashi K, Unoura M, Hattori S. Diagnosis of hepatocellular carcinoma in its early stage for the aim of the curable hepatectomy; with special reference to high risk liver cirrhosis. Acta Hepatol Jpn 1989; 30 Suppl 1: 37.
11. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K. Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154: 10-24.
12. Okuda K, Tanaka M, Nakayama T, Saitsu H, Tanikawa K, Nakashima O, Kojiro M. Clinicopathologic comparsion between resected hepatocellular carcinoma (HCC) and recurrent tumors. Int Hepatol Commun 1993; 1: 65-71.
13. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 1994; 54: 448-54.
14. Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M, Ogawa N. A multicenter randomized control clinical trial of Sho-saiko-to in chronic active hepatitis. Gastroenterol Jpn 1989; 24: 715-9.
15. Suzuki H, Ohta Y, Takino T, Fujisawa K, Hirayama C. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis-double blind trial. Asian Med J 1983; 26: 423-38.
16. Bellentani S, Podda M, Tiribelli C, Callea F, Marazzi M, Sodde M, Merlini R, Batezzati PM, Crosignani A, Zvin M. Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial. J Hepatol 1993; 19: 459-64.
17. Vasiliev JM, Moizhess TG. Tumorigenicity of sarcoma cells is enhanced by the local environment of implanted foreign body. Int J Cancer 1982; 30: 525-9.
18. Hamada J, Takeichi N, Okada F, Ren J, Li X, Hosokawa M, Kobayashi H. Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn J Cancer Res 1992; 83: 483-90.
19. Craddock VM. Liver carcinomas induced in rat by single administration of dimethylnitrosamine after partial hepatectomy. J Natl Cancer Inst 1971; 47: 889-907.
20. Craddock VM. Induction of liver tumors in rats by a single treatment with nitroso compounds given partial hepatectomy. Nature 1973; 245: 386-8.
21. Craddock VM, Frei JV. Induction of liver cell adenomata in the rat by a single treatment with N-methyl-N-nitrosourea given at various times after partial hepatectomy. Br J Cancer 1974; 30: 503-11.
22. Yamasaki S, Hasegawa H, Takayama T, Kosuge T, Shimada S, Yamamoto J. Clinicopathological features of recurrent primary liver cancer in Japan. In: Tobe T, Kameda H, Okuda K, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M, editors. Primary liver cancer in Japan. Tokyo: Springer; 1992. p. 345-51.
23. Ito K, Ohba N, Toyama K, Matsumoto M. Metachronous hepatoneocarcinogenesis following curative resection of hepatocellular carcinoma. Jpn J Gastroenterol 1994; 19: 8-22 (in Japanese).
24. Schmidt E, Schmidt FW, Wildhirt E. Activitäts-Bestimmungen von enzymen des energieliefernden stoffwechsels in menschlichen serum und in leberpunktaten bei leberkrankungen. Klin Wschr 1958; 36: 280-7.
25. Baier H, Hennemann G, Mühler E. Beitrag zur aktvitätsbeurteilung chronischer Leberekrankungen druch bestimmung von serumenzymen. Klin Wschr 1961; 39: 117-9.
26. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474-6.
27. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, Tamai S, Hoshino H, Inoue T, Kanisawa M. Significance of hepatocellular proliferation in the development of hepatpcellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1994; 73: 1149-54.
28. Tarao K, Shimizu A, Ohkawa S, Tamai S. Prediction of the development of hepatocellular carcinoma from HCV associated liver cirrhosis. J Jpn Soc Intern Med 1995; 84: 1985-91.